Glucotrack, Inc. Files 8-K
Ticker: GCTK · Form: 8-K · Filed: Feb 14, 2025 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Feb 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financials
TL;DR
Glucotrack filed an 8-K on Feb 14, 2025, covering Reg FD and financials.
AI Summary
Glucotrack, Inc. filed an 8-K on February 14, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ.
Why It Matters
This filing provides an update on Glucotrack's regulatory disclosures and financial reporting, which are important for investors to understand the company's current status.
Risk Assessment
Risk Level: low — This is a routine filing for current reports and does not indicate any specific new risks.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- February 14, 2025 (date) — Date of earliest event reported
- Integrity Applications, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Rutherford, NJ (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Glucotrack, Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to provide financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on February 14, 2025.
What was Glucotrack, Inc. previously named?
Glucotrack, Inc. was previously named Integrity Applications, Inc. and GlucoTrack, Inc.
In which state is Glucotrack, Inc. incorporated?
Glucotrack, Inc. is incorporated in Delaware.
Where are Glucotrack, Inc.'s principal executive offices located?
Glucotrack, Inc.'s principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.
Filing Stats: 474 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-02-14 16:05:38
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 246KB
- ex99-1_002.jpg (GRAPHIC) — 660KB
- ex99-1_003.jpg (GRAPHIC) — 312KB
- ex99-1_004.jpg (GRAPHIC) — 479KB
- ex99-1_005.jpg (GRAPHIC) — 438KB
- ex99-1_006.jpg (GRAPHIC) — 390KB
- ex99-1_007.jpg (GRAPHIC) — 404KB
- ex99-1_008.jpg (GRAPHIC) — 398KB
- ex99-1_009.jpg (GRAPHIC) — 362KB
- ex99-1_010.jpg (GRAPHIC) — 337KB
- ex99-1_011.jpg (GRAPHIC) — 259KB
- ex99-1_012.jpg (GRAPHIC) — 379KB
- ex99-1_013.jpg (GRAPHIC) — 472KB
- ex99-1_014.jpg (GRAPHIC) — 140KB
- ex99-1_015.jpg (GRAPHIC) — 552KB
- ex99-1_016.jpg (GRAPHIC) — 657KB
- ex99-1_017.jpg (GRAPHIC) — 130KB
- 0001493152-25-006856.txt ( ) — 9326KB
- gctk-20250214.xsd (EX-101.SCH) — 3KB
- gctk-20250214_lab.xml (EX-101.LAB) — 33KB
- gctk-20250214_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 14, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer